Executive Summary
Antisoma is a biotechnology company specialising in the development of novel anti-cancer drugs. Antisoma has a diverse portfolio of products in development. It has three products which are being evaluated in clinical trials and three in preclinical development. Antisoma's products target tumours by several different mechanisms and are intended for the treatment of a range of cancers.
Company History
Current Events
Business Model
Products/Services
Segments/Customers
Production/Operations
Distribution/Routes to Market
Market & Competition
Market Share
Main Competitors
Competitive Strengths and Weaknesses
Management
Financials
Profit & Loss
Balance sheet
Cashflow
Valuation
Comparable Companies
SWOT Analysis
Strengths
Weaknesses
Opportunities
Threats
